Protocol For the Treatment of Cryptosporidiosis in AIDS Patients With Diclazuril (R64,433)
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To evaluate the safety and efficacy of diclazuril capsules compared with placebo capsules as
treatment of cryptosporidial related diarrhea in AIDS patients. Treatment efficacy will be
based on the drug's clinical results and on its anti-protozoan effects. Safety will be
assessed by the occurrence of side effects as reported by patients at their visits and by
frequent monitoring of hematology, biochemistries, and urinalysis.